Skip navigation

University College Dublin Logo
SEARCH UCD

Advanced Search
 
 
 

UCD News

Nuacht UCD

Posted: 01 October 2007

Medical tech firm locates new division at NovaUCD

Alltracel Healthcare Services (AHS), the newly created division of AIM listed Alltracel Pharmaceuticals has located to
NovaUCD
, the Innovation and Technology Transfer Centre at University College Dublin.

AHS will provide scientific research, clinical trial and development services for all of Alltracel’s business units, subsidiaries and relevant partnerships. Its services will also be available to outside companies in the pharmaceutical, medical and healthcare technologies sectors who are seeking an external step-up in speed of innovation, technology development and commercialisation.

“We have always had a great working relationship with UCD in particular with the UCD Conway Institute, so we are very pleased to be able to base Alltracel Healthcare Services in NovaUCD,” said Dr Keith Real, Chief Scientific Officer, Alltracel.

AHS is led by ex-ICON senior manager, Conor Walshe and will be directed by Alltracel’s Chief Scientific Officer, Dr Keith Real with guidance by Alltracel’s Scientific Advisory Board.

“We are delighted that Alltracel Pharmaceuticals which already has strong research links with UCD and with a proven record in innovation has decided to base its new division at NovaUCD,” said Dr Pat Frain, Director, NovaUCD. “The strategic importance of this relationship is clear since AHS will be offering multinational companies an outsourced partner that will facilitate and co-ordinate their R&D requirements in a flexible and timely way.”

Alltracel Pharmaceuticals plc (Alltracel) is the Healthcare Innovation Group focused on taking proprietary technology from research through to commercialisation in the global healthcare market. Alltracel was founded in 1996 and is a public company listed on London’s Alternative Investment Market.

Alltracel’s corporate headquarters are located in Dublin and the company has commercial offices on London, an R&D subsidiary in the Czech Republic and manufacturing facilities in Shenzhen, China. In addition to Alltracel Healthcare Services, Alltracel operates via two other main divisions, Alltracel Healthcare Group and Alltracel Healthcare Technologies.

 

Top Right: Pictured at the announcement that Alltracel Healthcare Services, the newly created division of AIM listed Alltracel Pharmaceuticals has located at NovaUCD were Dr Keith Real, Chief Scientific Officer, Alltracel Pharmaceuticals (right) and Dr Pat Frain, Director, NovaUCD.

>> More News and Events
<< Back to Home

Pictured at the announcement that Alltracel Healthcare Services, the newly created division of AIM listed Alltracel Pharmaceuticals has located at NovaUCD were Dr Keith Real, Chief Scientific Officer, Alltracel Pharmaceuticals (right) and Dr Pat Frain, Director, NovaUCD.